PATENT ASSIGNMENT AGREEMENTPatent Assignment Agreement • July 15th, 2022 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 15th, 2022 Company IndustryTHIS PATENT ASSIGNMENT AGREEMENT (this “Agreement”) is dated as of April 1 , 2022 (“Effective Date”), and is made by and between HESP LLC, a Delaware limited liability company (“Assignor”), and Cadrenal Therapeutics Inc., a Delaware corporation (“Assignee”). Each of Assignor and Assignee may be referenced herein as a “Party,” and collectively, the “Parties.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 15th, 2022 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 15th, 2022 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”), dated as of April 1 , 2022, by and between HESP LLC, a Delaware limited liability company (“Seller”) and Cadrenal Therapeutics Inc., a Delaware corporation (“Purchaser”). Article 8 contains definitions of certain capitalized terms used herein and also provides cross-references to certain capitalized terms defined elsewhere in this Agreement.